AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Centerspace

$58.62 -$8.35 (-12.47%)
NYSE · 14 Sep 2026 20:00 UTC
Previous Close
$58.29
Day Range
$57.25$58.79
Year Range
$52$69.61
Market Cap
985M
AVG Volume
180.13K
Trailing/Forward PE
45.47/-
PEG ratio
-0.88
Dividend Yield
5.25%
Next Earnings Date
2026-11-02
Primary Exchange
New York Stock ExchangeUS
Revenue (USD)
0100M200M300M2016201720182019202020212022202320242025
CSR Revenue (USD) by year
PeriodRevenue (USD)
2025273.66M
2024260.98M
2023261.31M
2022256.72M
2021201.71M
2020177.99M
2019185.75M
2018181.5M
2017204.25M
2016199.92M
Net Income (USD)
-50M050M100M150M200M2016201720182019202020212022202320242025
CSR Net Income (USD) by year
PeriodNet Income (USD)
202517.59M
2024-10.69M
202341.97M
2022-15.02M
2021611K
20205.08M
201979.21M
2018-26.81M
2017167.94M
201624.07M
Operating Income (USD)
-25M025M50M75M100M2016201720182019202020212022202320242025
CSR Operating Income (USD) by year
PeriodOperating Income (USD)
20258.66M
202420.48M
202384.45M
202215.52M
20213.05M
20208.34M
201911.42M
201813.07M
20179.36M
2016-13.27M
EBITDA (USD)
050M100M150M200M2016201720182019202020212022202320242025
CSR EBITDA (USD) by year
PeriodEBITDA (USD)
2025182.49M
2024130.74M
2023188.83M
2022120.68M
202195.5M
202086.11M
201994.38M
201880.3M
201798.69M
201633.75M
Cash Flows (USD)
020M40M60M80M2016201720182019202020212022202320242025
CSR Cash Flows (USD) by year
PeriodCash Flows (USD)
202579.38M
202441.59M
202330.7M
202235.42M
202148.15M
202030.91M
201948.67M
201850.13M
201739.83M
201633.46M
EPS (USD)
-50510152016201720182019202020212022202320242025
CSR EPS (USD) by year
PeriodEPS (USD)
20251
2024-1.04
20235.42
2022-0.98
20210.16
20200.29
20196.19
2018-2.11
201713.17
20161.42
Expenses (USD)
020M40M60M80MSG&ACapex2016201720182019202020212022202320242025
CSR Expenses (USD) by year
PeriodExpenses (USD)
202545.04M
202474.46M
202378.91M
202275.68M
202152.09M
202043.76M
201935.4M
201815.11M
201734.96M
201653.18M
Cash & Debt (USD)
0500M1B1.5BCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
CSR Cash & Debt (USD) by year
PeriodCash & Debt (USD)
202512.83M
202412.03M
20238.63M
202210.46M
202131.27M
2020392K
201926.58M
201814.61M
201722.67M
201657M
Debt ratios
012320182019202020212022202320242025
CSR Debt ratios by year
PeriodDebt ratios
20251.62
20241.76
20231.85
20222.51
20212.31
20202
20192.03
20181.84
Margins
0%20%40%60%2016201720182019202020212022202320242025
CSR Margins by year
PeriodMargins
202557.64%
202456.94%
202355.93%
202253.83%
202155.08%
202055.64%
201954.51%
201855.08%
201754.99%
201656.72%
Return on Capital
-10%0%10%20%30%2016201720182019202020212022202320242025
CSR Return on Capital by year
PeriodReturn on Capital
20252.08%
2024-1.19%
20234.43%
2022-1.55%
20210.06%
20200.74%
201911.37%
2018-4.13%
201723.22%
20163.87%
Shares Outstanding
05M10M15M20M2016201720182019202020212022202320242025
CSR Shares Outstanding by year
PeriodShares Outstanding
202516.73M
202416.58M
202315.01M
202215.03M
202114.45M
202013.01M
201911.89M
201813.32M
201711.97M
201612.13M
Dividends (USD)
012342017201820192020202120222023202420252026
CSR Dividends (USD) by year
PeriodDividends (USD)
20262.31
20253.08
20243
20232.92
20222.92
20212.84
20202.8
20192.8
20182.8
20172.8
Employee Count
02004006002016201720182019202020212022202320242025
CSR Employee Count by year
PeriodEmployee Count
2025334
2024374
2023377
2022421
2021394
2020340
2019392
2018527
2017523
2016483
Book Value Per Share (USD)
0204060802016201720182019202020212022202320242025
CSR Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
202550.56
202454.21
202363.12
202264.34
202170.7
202052.99
201958.59
201848.77
201760.41
201651.23
Total Assets (USD)
01B2B3B2016201720182019202020212022202320242025
CSR Total Assets (USD) by year
PeriodTotal Assets (USD)
20251.93B
20241.91B
20231.93B
20222.03B
20211.94B
20201.46B
20191.39B
20181.34B
20171.46B
20161.61B
PE Ratio
050100150med 24.94Jul 23Nov 23Feb 24Nov 25Feb 26Jun 26Sep 26
CSR PE Ratio by year
PeriodPE Ratio
Sep 2645.36
Sep 2645.11
Sep 2640.94
Aug 2640.61
Aug 2641.76
Aug 2643.21
Aug 2643.86
Jul 26110.45
Jul 26112.24
Jul 26112.42
Jul 26111.92
Jul 26115.28
Jun 26114.8
Jun 26112.08
Jun 26117.6
Jun 26119.35
May 26135.91
May 26137.44
May 26134.88
May 26136.25
May 2665.04
Apr 2663.24
Apr 2661.92
Apr 2660.8
Apr 2656.97
Mar 2654.95
Mar 2654.26
Mar 2658.99
Mar 2660.01
Feb 2659.83
Feb 2659.1
Feb 2634.25
Feb 2634.62
Jan 2634.63
Jan 2634.54
Jan 2634.85
Jan 2635.87
Jan 2636.08
Dec 2536.21
Dec 2535.2
Dec 2535.29
Dec 2534.32
Nov 2535.97
Nov 2535.94
Nov 2536.03
Nov 2532.23
May 2424.23
May 2424.91
May 2425.12
May 2424.58
Apr 2423.11
Apr 2423.21
Apr 2421.73
Apr 2420.03
Mar 2420.44
Mar 2420.36
Mar 2420.08
Mar 2420.31
Mar 2420.03
Feb 2420.13
Feb 2417.59
Feb 2417.05
Feb 2417.04
Jan 2417.5
Jan 2417.81
Jan 2417.56
Jan 2417.01
Dec 2318.25
Dec 2318.15
Dec 2318.18
Dec 2317.09
Dec 2317.04
Nov 2316.99
Nov 2316.66
Nov 2316.09
Nov 2315.94
Oct 2318.23
Oct 2320.23
Oct 2321.52
Oct 2322.1
Sep 2322.97
Sep 2323
Sep 2323.79
Sep 2323.66
Sep 2324.43
Aug 2323.84
Aug 2323.05
Aug 2324.25
Aug 2324.43
Jul 2324.2
Jul 2325.4
Jul 2325.9
Jul 2324.86
Jun 2324.43
Jun 2323.11
Jun 2324.95
Jun 2324.92
Jun 2324.66
May 2323.4
May 2323.6
Free Cash Flow Yield
2%4%6%8%10%med 6.89%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CSR Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 267.06%
Sep 267.1%
Sep 267.83%
Aug 267.89%
Aug 267.67%
Aug 267.41%
Aug 267.3%
Jul 267.61%
Jul 267.49%
Jul 267.48%
Jul 267.51%
Jul 267.3%
Jun 267.33%
Jun 267.5%
Jun 267.15%
Jun 267.05%
May 266.19%
May 266.12%
May 266.24%
May 266.17%
May 266.94%
Apr 267.14%
Apr 267.29%
Apr 267.42%
Apr 267.92%
Mar 268.21%
Mar 268.32%
Mar 267.65%
Mar 267.52%
Feb 267.54%
Feb 267.64%
Feb 267.16%
Feb 267.08%
Jan 267.08%
Jan 267.1%
Jan 267.03%
Jan 266.83%
Jan 266.8%
Dec 256.77%
Dec 256.96%
Dec 256.95%
Dec 257.14%
Nov 256.82%
Nov 256.82%
Nov 256.81%
Nov 257.61%
Oct 257.15%
Oct 257.1%
Oct 257.03%
Oct 257.29%
Oct 257.18%
Sep 257.21%
Sep 257.26%
Sep 257.25%
Sep 257%
Aug 257.12%
Aug 257.28%
Aug 257.65%
Aug 257.91%
Aug 257.11%
Jul 256.69%
Jul 256.56%
Jul 256.41%
Jul 256.31%
Jun 256.41%
Jun 256.18%
Jun 256.06%
Jun 256.03%
May 256.04%
May 256.3%
May 256.09%
May 256.28%
May 256.27%
Apr 254.21%
Apr 254.34%
Apr 254.4%
Apr 254.17%
Mar 253.94%
Mar 253.93%
Mar 253.98%
Mar 253.82%
Feb 253.79%
Feb 253.91%
Feb 252.56%
Feb 252.59%
Jan 252.63%
Jan 252.62%
Jan 252.62%
Jan 252.65%
Jan 252.44%
Dec 242.43%
Dec 242.42%
Dec 242.3%
Dec 242.28%
Nov 242.21%
Nov 242.17%
Nov 242.2%
Nov 242.15%
Nov 242.39%
Oct 242.08%
Price to Sales
33.544.5med 3.84Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CSR Price to Sales by year
PeriodPrice to Sales
Sep 263.66
Sep 263.64
Sep 263.31
Aug 263.28
Aug 263.37
Aug 263.49
Aug 263.54
Jul 263.39
Jul 263.44
Jul 263.45
Jul 263.43
Jul 263.53
Jun 263.52
Jun 263.44
Jun 263.61
Jun 263.66
May 264.17
May 264.21
May 264.14
May 264.18
May 264.18
Apr 264.06
Apr 263.98
Apr 263.91
Apr 263.66
Mar 263.53
Mar 263.49
Mar 263.79
Mar 263.86
Feb 263.84
Feb 263.8
Feb 263.89
Feb 263.93
Jan 263.93
Jan 263.92
Jan 263.96
Jan 264.07
Jan 264.1
Dec 254.11
Dec 254
Dec 254.01
Dec 253.9
Nov 254.08
Nov 254.08
Nov 254.09
Nov 253.66
Oct 253.71
Oct 253.74
Oct 253.78
Oct 253.64
Oct 253.7
Sep 253.68
Sep 253.66
Sep 253.66
Sep 253.79
Aug 253.73
Aug 253.65
Aug 253.47
Aug 253.35
Aug 253.44
Jul 253.66
Jul 253.73
Jul 253.81
Jul 253.88
Jun 253.81
Jun 253.95
Jun 254.03
Jun 254.05
May 254.05
May 253.88
May 254.02
May 253.9
May 253.9
Apr 253.78
Apr 253.67
Apr 253.62
Apr 253.83
Mar 254.05
Mar 254.05
Mar 254.01
Mar 254.17
Feb 254.21
Feb 254.07
Feb 253.74
Feb 253.7
Jan 253.65
Jan 253.67
Jan 253.66
Jan 253.62
Jan 253.94
Dec 243.96
Dec 243.96
Dec 244.17
Dec 244.2
Nov 244.35
Nov 244.43
Nov 244.35
Nov 244.47
Nov 244.01
Oct 244.08
EV/EBITDA
1012141618med 14.54Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CSR EV/EBITDA by year
PeriodEV/EBITDA
Sep 2610.67
Sep 2610.64
Sep 2610.15
Aug 2610.11
Aug 2610.25
Aug 2610.42
Aug 2610.5
Jul 2611.27
Jul 2611.36
Jul 2611.37
Jul 2611.34
Jul 2611.51
Jun 2611.48
Jun 2611.35
Jun 2611.62
Jun 2611.7
May 2612.51
May 2612.58
May 2612.46
May 2612.53
May 2611.79
Apr 2611.62
Apr 2611.49
Apr 2611.38
Apr 2611.02
Mar 2610.82
Mar 2610.75
Mar 2611.21
Mar 2611.31
Feb 2611.29
Feb 2611.22
Feb 2611.28
Feb 2611.33
Jan 2611.34
Jan 2611.32
Jan 2611.37
Jan 2611.54
Jan 2611.57
Dec 2511.59
Dec 2511.43
Dec 2511.44
Dec 2511.29
Nov 2511.55
Nov 2511.55
Nov 2511.56
Nov 2510.95
Oct 2517.4
Oct 2517.45
Oct 2517.54
Oct 2517.23
Oct 2517.37
Sep 2517.32
Sep 2517.27
Sep 2517.28
Sep 2517.57
Aug 2517.44
Aug 2517.25
Aug 2516.86
Aug 2516.6
Aug 2513.97
Jul 2514.4
Jul 2514.55
Jul 2514.71
Jul 2514.84
Jun 2514.71
Jun 2514.99
Jun 2515.15
Jun 2515.19
May 2515.18
May 2514.85
May 2515.12
May 2514.88
May 2514.88
Apr 2514.77
Apr 2514.54
Apr 2514.44
Apr 2514.85
Mar 2515.3
Mar 2515.31
Mar 2515.21
Mar 2515.54
Feb 2515.61
Feb 2515.35
Feb 2515.04
Feb 2514.95
Jan 2514.84
Jan 2514.88
Jan 2514.86
Jan 2514.78
Jan 2515.43
Dec 2415.47
Dec 2415.49
Dec 2415.92
Dec 2415.99
Nov 2416.3
Nov 2416.45
Nov 2416.3
Nov 2416.54
Nov 2415.58
Oct 2414.7
Price/Operating Cashflow
8910111213med 10.36Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CSR Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 2610.72
Sep 2610.66
Sep 269.68
Aug 269.6
Aug 269.87
Aug 2610.22
Aug 2610.37
Jul 269.74
Jul 269.9
Jul 269.91
Jul 269.87
Jul 2610.17
Jun 2610.12
Jun 269.88
Jun 2610.37
Jun 2610.53
May 2611.99
May 2612.12
May 2611.89
May 2612.02
May 2611.62
Apr 2611.3
Apr 2611.06
Apr 2610.86
Apr 2610.18
Mar 269.82
Mar 269.69
Mar 2610.54
Mar 2610.72
Feb 2610.69
Feb 2610.56
Feb 2610.18
Feb 2610.29
Jan 2610.3
Jan 2610.27
Jan 2610.36
Jan 2610.67
Jan 2610.73
Dec 2510.77
Dec 2510.47
Dec 2510.49
Dec 2510.2
Nov 2510.69
Nov 2510.68
Nov 2510.71
Nov 259.58
Oct 259.76
Oct 259.82
Oct 259.92
Oct 259.56
Oct 259.72
Sep 259.66
Sep 259.6
Sep 259.62
Sep 259.96
Aug 259.8
Aug 259.58
Aug 259.11
Aug 258.81
Aug 259.13
Jul 259.71
Jul 259.9
Jul 2510.12
Jul 2510.29
Jun 2510.12
Jun 2510.5
Jun 2510.7
Jun 2510.76
May 2510.74
May 2510.31
May 2510.67
May 2510.34
May 2510.35
Apr 2510.05
Apr 259.75
Apr 259.62
Apr 2510.16
Mar 2510.76
Mar 2510.77
Mar 2510.64
Mar 2511.07
Feb 2511.17
Feb 2510.82
Feb 2510.56
Feb 2510.44
Jan 2510.29
Jan 2510.35
Jan 2510.33
Jan 2510.21
Jan 2511.1
Dec 2411.16
Dec 2411.18
Dec 2411.76
Dec 2411.86
Nov 2412.28
Nov 2412.48
Nov 2412.28
Nov 2412.61
Nov 2411.31
Oct 2411.55
Price to Book
11.11.21.31.41.5med 1.18Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CSR Price to Book by year
PeriodPrice to Book
Sep 261.23
Sep 261.23
Sep 261.11
Aug 261.11
Aug 261.14
Aug 261.18
Aug 261.19
Jul 261.13
Jul 261.15
Jul 261.15
Jul 261.14
Jul 261.18
Jun 261.17
Jun 261.14
Jun 261.2
Jun 261.22
May 261.39
May 261.4
May 261.38
May 261.39
May 261.35
Apr 261.32
Apr 261.29
Apr 261.26
Apr 261.18
Mar 261.14
Mar 261.13
Mar 261.23
Mar 261.25
Feb 261.24
Feb 261.23
Feb 261.2
Feb 261.21
Jan 261.21
Jan 261.21
Jan 261.22
Jan 261.26
Jan 261.26
Dec 251.27
Dec 251.23
Dec 251.24
Dec 251.2
Nov 251.26
Nov 251.26
Nov 251.26
Nov 251.13
Oct 251.17
Oct 251.18
Oct 251.19
Oct 251.15
Oct 251.17
Sep 251.16
Sep 251.16
Sep 251.16
Sep 251.2
Aug 251.18
Aug 251.15
Aug 251.1
Aug 251.06
Aug 251.03
Jul 251.09
Jul 251.12
Jul 251.14
Jul 251.16
Jun 251.14
Jun 251.18
Jun 251.21
Jun 251.21
May 251.21
May 251.16
May 251.2
May 251.17
May 251.17
Apr 251.1
Apr 251.07
Apr 251.05
Apr 251.11
Mar 251.18
Mar 251.18
Mar 251.16
Mar 251.21
Feb 251.22
Feb 251.18
Feb 251.07
Feb 251.06
Jan 251.04
Jan 251.05
Jan 251.05
Jan 251.03
Jan 251.12
Dec 241.13
Dec 241.13
Dec 241.19
Dec 241.2
Nov 241.24
Nov 241.26
Nov 241.24
Nov 241.28
Nov 241.15
Oct 241.15
Centerspace
CSR
Stockpicker

Video analysis: CSR

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: CSR

New Strong Sell Stocks for September 11th

zacks.com · 11 Sep 2026

New Strong Sell Stocks for September 11th

DKS, AU and CSR have been added to the Zacks Rank #5 (Strong Sell) List on September 11, 2026.

Centerspace Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centerspace - CSR

gurufocus.com · 10 Sep 2026

Centerspace Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centerspace - CSR

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swick and Foti[/url], LLC (“KSF”) are investigating the propos

Centerspace Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centerspace - CSR

businesswire.com · 10 Sep 2026

Centerspace Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centerspace - CSR

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Centerspace (NYSE: CSR) to Independence Realty Trust, Inc. (NYSE: IRT). Under the terms of the proposed transaction, shareholders of Centerspace will receive 3.800 shares of Independence Realty common stock for each share of Centerspace that they own. KSF is seeking to determine whether this conside.

Medicus Pharma Publishes Abridged Final Phase 2 SkinJect® Clinical Study Report (CSR) Results Identifying 200 µg D-MNA Patch as the Lead Development Dose

globenewswire.com · 10 Sep 2026

Medicus Pharma Publishes Abridged Final Phase 2 SkinJect® Clinical Study Report (CSR) Results Identifying 200 µg D-MNA Patch as the Lead Development Dose

CSR provides a clinical foundation for the Company's recently announced capital-efficient focus on FDA-authorized Gorlin Syndrome NDA-enabling development program while supporting partnership discussions to advance nodular Basal Cell Carcinoma CSR provides a clinical foundation for the Company's recently announced capital-efficient focus on FDA-authorized Gorlin Syndrome NDA-enabling development program while supporting partnership discussions to advance nodular Basal Cell Carcinoma

Why Independence Realty Trust Stock Sank Today

fool.com · 9 Sep 2026

Why Independence Realty Trust Stock Sank Today

It's essentially acquiring a peer REIT.

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Centerspace (NYSE: CSR)

prnewswire.com · 9 Sep 2026

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Centerspace (NYSE: CSR)

NEW YORK, Sept. 9, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report.

Are CSR, BZH, IRT Obtaining Fair Deals for their Shareholders?

gurufocus.com · 9 Sep 2026

Are CSR, BZH, IRT Obtaining Fair Deals for their Shareholders?

Are CSR, BZH, IRT Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Sept. 9, 2026

Centerspace (CSR) M&A Call Transcript

seekingalpha.com · 9 Sep 2026

Centerspace (CSR) M&A Call Transcript

Centerspace (CSR) M&A Call Transcript

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.